429 related articles for article (PubMed ID: 34086550)
21. Hypoxia-inducible factor 1 alpha and nuclear-related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's disease.
Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1141-1150. PubMed ID: 31408200
[TBL] [Abstract][Full Text] [Related]
22. Potential risks and benefits of phytoestrogen-rich diets.
Cassidy A
Int J Vitam Nutr Res; 2003 Mar; 73(2):120-6. PubMed ID: 12747219
[TBL] [Abstract][Full Text] [Related]
23. Increased Beta-Hydroxybutyrate Level Is Not Sufficient for the Neuroprotective Effect of Long-Term Ketogenic Diet in an Animal Model of Early Parkinson's Disease. Exploration of Brain and Liver Energy Metabolism Markers.
Kuter KZ; Olech Ł; Głowacka U; Paleczna M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299176
[TBL] [Abstract][Full Text] [Related]
24. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture.
Zava DT; Blen M; Duwe G
Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):637-45. PubMed ID: 9168008
[TBL] [Abstract][Full Text] [Related]
25. Phytoestrogens in health and disease.
Davis SR; Dalais FS; Simpson ER; Murkies AL
Recent Prog Horm Res; 1999; 54():185-210; discussion 210-1. PubMed ID: 10548876
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective strategies in Parkinson's disease : an update on progress.
Mandel S; Grünblatt E; Riederer P; Gerlach M; Levites Y; Youdim MB
CNS Drugs; 2003; 17(10):729-62. PubMed ID: 12873156
[TBL] [Abstract][Full Text] [Related]
27. Regulation of estrogen receptor beta mRNA in the brain: opposite effects of 17beta-estradiol and the phytoestrogen, coumestrol.
Patisaul HB; Whitten PL; Young LJ
Brain Res Mol Brain Res; 1999 Apr; 67(1):165-71. PubMed ID: 10101243
[TBL] [Abstract][Full Text] [Related]
28. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.
Kostelac D; Rechkemmer G; Briviba K
J Agric Food Chem; 2003 Dec; 51(26):7632-5. PubMed ID: 14664520
[TBL] [Abstract][Full Text] [Related]
29. Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons.
Richter F; Gao F; Medvedeva V; Lee P; Bove N; Fleming SM; Michaud M; Lemesre V; Patassini S; De La Rosa K; Mulligan CK; Sioshansi PC; Zhu C; Coppola G; Bordet T; Pruss RM; Chesselet MF
Neurobiol Dis; 2014 Sep; 69():263-75. PubMed ID: 24844147
[TBL] [Abstract][Full Text] [Related]
30. Coexposure to phytoestrogens and bisphenol a mimics estrogenic effects in an additive manner.
Katchy A; Pinto C; Jonsson P; Nguyen-Vu T; Pandelova M; Riu A; Schramm KW; Samarov D; Gustafsson JÅ; Bondesson M; Williams C
Toxicol Sci; 2014 Mar; 138(1):21-35. PubMed ID: 24284790
[TBL] [Abstract][Full Text] [Related]
31. Beneficial Effects of Flavonoids Against Parkinson's Disease.
Jung UJ; Kim SR
J Med Food; 2018 May; 21(5):421-432. PubMed ID: 29412767
[TBL] [Abstract][Full Text] [Related]
32. Current Therapeutic Strategies and Perspectives for Neuroprotection in Parkinson's Disease.
Ghanta MK; Elango P; L V K S B
Curr Pharm Des; 2020; 26(37):4738-4746. PubMed ID: 32065086
[TBL] [Abstract][Full Text] [Related]
33. Phytoestrogens as neuroprotectants.
Schreihofer DA
Drugs Today (Barc); 2009 Aug; 45(8):609-27. PubMed ID: 19927227
[TBL] [Abstract][Full Text] [Related]
34. Impact of the phytoestrogen content of laboratory animal feed on the gene expression profile of the reproductive system in the immature female rat.
Naciff JM; Overmann GJ; Torontali SM; Carr GJ; Tiesman JP; Daston GP
Environ Health Perspect; 2004 Nov; 112(15):1519-26. PubMed ID: 15531437
[TBL] [Abstract][Full Text] [Related]
35. Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens.
Gillies GE; McArthur S
Horm Behav; 2010 Jan; 57(1):23-34. PubMed ID: 19538962
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson's Disease.
Miyazaki I; Asanuma M
Curr Pharm Des; 2017; 23(33):4936-4947. PubMed ID: 28699520
[TBL] [Abstract][Full Text] [Related]
37. Phytoestrogens: The current state of research emphasizing breast pathophysiology.
Anandhi Senthilkumar H; Fata JE; Kennelly EJ
Phytother Res; 2018 Sep; 32(9):1707-1719. PubMed ID: 29876983
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons.
Zhao L; Chen Q; Diaz Brinton R
Exp Biol Med (Maywood); 2002 Jul; 227(7):509-19. PubMed ID: 12094016
[TBL] [Abstract][Full Text] [Related]
39. Protective Effect of Tocotrienol on In Vitro and In Vivo Models of Parkinson's Disease.
Matsura T
J Nutr Sci Vitaminol (Tokyo); 2019; 65(Supplement):S51-S53. PubMed ID: 31619646
[TBL] [Abstract][Full Text] [Related]
40. Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors alpha and beta in vitro.
Casanova M; You L; Gaido KW; Archibeque-Engle S; Janszen DB; Heck HA
Toxicol Sci; 1999 Oct; 51(2):236-44. PubMed ID: 10543025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
